Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
P/E Ratio HistoryNormalizing
Percentile Rank75
Studio
Year-over-Year Change

Price-to-earnings ratio

Percentile
P75
Within normal range
vs 2Y Ago
-0.3x
Contraction
Streak
1 yr
Consecutive growthNormalizing
PeriodValueYoY Change
2025-5.28+21.3%
2024-6.71-139.2%
202317.13+207.4%
2022-15.96-19.6%
2021-13.34-